|
Match
|
Document |
Document Title |
|
|
US20150224078 |
Methods for the Treatment of Lung Diseases with Mast Cell Stabilizers
Methods for the treatment of lung diseases with mast cell stabilizers are provided. |
|
|
US20150224077 |
Methods for the Treatment of Systemic Disorders Treatable with Mast Cell Stabilizers, including Mast Cell Related Disorders
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided. |
|
|
US20120040921 |
COMPOSITIONS AND PRODUCTS CONTAINING S-EQUOL, AND METHODS FOR THEIR MAKING
A composition for use in making commercial food and skin products comprising 5-equol or mixtures, including both a non-racemic mixture and a racemic mixture, of S-equol and R-equol. The... |
|
|
US20110212989 |
THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING ISOFLAVONES
Therapeutic method of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (I), in which Z is H, R1 is H or RACO wherein Ra is... |
|
|
US20110182857 |
Delivery of Drugs to Mucosal Surfaces
Liquid pharmaceutical compositions for administration to a mucosal surface, including a therapeutic agent and a pectin with a low degree of esterification are described. Such compositions gel, or... |
|
|
US20090131340 |
USE OF FLAVONOIDS AS IMMUNOMODULATING OR IMMUNO-PROTECTIVE AGENTS IN COSMETIC AND DERMATOLOGICAL PREPARATIONS
A method of treating or prophylactically treating immunosuppression or allergic and inflammatory symptoms of skin caused by UVB radiation which comprises applying to the skin a cosmetic or... |
|
|
US20090088394 |
METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT
Methods and compositions are described for the modulation of central nervous system and/or fetal effects of substances. Methods and compositions are described for the modulation of efflux... |
|
|
US20090076053 |
METHODS AND COMPOSITIONS FOR TREATING PAIN
Methods and compositions are described for the modulation of central nervous system and/or fetal effects of substances. Methods and compositions are described for the modulation of efflux... |
|
|
US20080124376 |
OCULAR DEVICES AND METHODS OF MAKING AND USING THEREOF
Described herein are stable ocular devices that immobilize and deliver bioactive agents to the eye over sustained periods of time. Also described herein are methods of making and using the ocular... |
|
|
US20080015155 |
Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye
The present invention relates to compositions comprising a proanthocyanidin, as well as methods for using such compositions in the treatment of an inflammatory condition of the skin including, but... |
|
|
US20060247183 |
Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
The present invention relates to compositions comprising a proanthocyanidin, as well as methods for using such compositions in the treatment of an inflammatory condition of the skin including, but... |
|
|
US20060111308 |
Methods and compositions for therapeutic treatment
Methods and compositions are described for the modulation of central nervous system and/or fetal effects of substances. Methods and compositions are described for the modulation of efflux... |
|
|
US20060111307 |
Methods and compositions for treating pain
Methods and compositions are described for the modulation of central nervous system and/or fetal effects of substances. Methods and compositions are described for the modulation of efflux... |
|
|
US20060079458 |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
The present invention relates to methods of improving a treatment outcome comprising administering a heat shock protein (HSP) preparation or an α-2-macroglobulin (α2M) preparation with a... |
|
|
US20050158249 |
Aerodynamically light particles for pulmonary drug delivery
Improved aerodynamically light particles for drug delivery to the pulmonary system, and methods for their synthesis and administration are provided. In a preferred embodiment, the aerodynamically... |
|
|
US20050059616 |
Therapeutic methods and compositions involving isoflavones
Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (I), in which Z is H, R1 is H, or RACO where RA is... |
|
|
US20050032873 |
3-Amino chroman and 2-amino tetralin derivatives
3-Amino chroman and 2-amino tetralin derivatives and compositions containing such compounds are disclosed. Methods of using the 3-amino chroman and 2-amino tetralin compounds and compositions... |
|
|
US20160346246 |
METHODS FOR THE TREATMENT OF LUNG DISEASES WITH MAST CELL STABILIZERS
Methods for the treatment of lung diseases with mast cell stabilizers are provided. |
|
|
US20150164932 |
Compositions That Include Anthocyanidins and Methods of Use
The compositions described herein and featured in the present invention include those that comprise anthocyanidin combinations rich in delphinidins, including delphinidins such as the ones found... |
|
|
US20140044685 |
NUTRITIONAL COMPOSITIONS HAVING ALPHA-HICA AND CITRULLINE
Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional... |
|
|
US20120301552 |
CaSR Antagonist
A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof: wherein each symbol is as defined in the specification. A... |
|
|
US20120269901 |
Methods and Compounds Useful to Induce Apoptosis in Cancer Cells
The present invention provides a method for treating cancer in a mammal comprising contacting the cancer cells with a compound which is a apogossypol, derivative. |
|
|
US20120071550 |
Synergistic combinations of cartonoids and polyphenols
The present invention provides a therapeutic composition comprising one or more polyphenols and one or more carotenoids selected from the group consisting of lutein, lycopene and beta-carotene.... |
|
|
US20080306136 |
Substituted Ureas and Carbamates
The invention provides compounds of formula I: useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in... |
|
|
US20080253976 |
Personal Care Compositions Comprising An Antimicrobial Blend of Essential Oils or Constituents Thereof
Disclosed are personal care compositions, including compositions for oral, throat and skin care comprising a blend of naturally occurring flavor or perfume ingredients or essential oils containing... |
|
|
US20070014733 |
Hydroxylated nebivolol metabolites
Hydroxylated nebivolol metabolites increase NO release from human endothelial cell preparations in a concentration dependent fashion following acute administration. In addition, hydroxylated... |
|
|
US20070003536 |
Topical skin compositions, their preparation, and their use
Topical skin compositions include a complex containing components to provide a defense against the various pathway mechanisms of free radicals, reactive oxygen species, reactive nitrogen species,... |
|
|
US20060286150 |
Therapeutic methods and compositions involving isoflavones
Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (I), in which Z is H, R1 is H, or RACO where RA is... |
|
|
US20060281694 |
Glucose levels
Disclosed are methods and compositions for improving blood glucose levels in a subject in need thereof. |
|
|
US20060276393 |
Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
Provided herein are methods and compositions for treating or preventing neurodegenerative disorders or blood coagulation disorders. Methods may comprise modulating the activity or level of a... |
|
|
US20050171027 |
Compositions for treating or preventing obesity and insulin resistance disorders
Provided herein are methods and compositions for modulating the activity or level of a sirtuin, thereby treating or preventing obesity or an insulin resistance disorder, such as diabetes in a... |
|
|
US20050037095 |
Compositions enriched in anthocyanins
This invention provides compositions enriched for anthocyanins and methods of preparation thereof from a crude plant extract. The method of preparation includes a novel column purification step... |
|
|
US20050003024 |
Regulation of mammalian hair growth
The present invention relates to a topical skin care composition containing a safe and effective amount of a skin care active comprising agmatine, and its salt; a safe and effective amount of a... |
|
|
US20160271101 |
Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders
The present invention relates to combination therapies for treating Alzheimer's disease or an amyloidosis-associated pathological condition comprising co-administering a therapeutically effective... |
|
|
US20160184387 |
COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
Provided are non-NHE3-binding agents having activity as phosphate transport/uptake inhibitors in the gastrointestinal tract, including in the small intestine, methods for their use as therapeutic... |
|
|
US20160166534 |
Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders
The present invention relates to combination therapies for treating Alzheimer's disease or an amyloidosis-associated pathological condition comprising co-administering a therapeutically effective... |
|
|
US20150238429 |
SOFT ELASTIC CAPSULES CONTAINING TABLETS AND LIQUID OR SEMISOLID FILLS AND METHODS FOR THEIR MANUFACTURE
Disclosed herein is a soft elastic capsule that includes an acid resistant, capsule shell that defines an encapsulated space having a predetermined volume, a liquid or semisolid fill comprising a... |
|
|
US20150080462 |
COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATING TO OXIDATIVE STRESS
The present invention features methods for treating or preventing conditions, diseases, or disorders related to oxidative stress. In one embodiment, the method increases Nrf2 biological activity... |
|
|
US20130225487 |
DIOXA-BICYCLO[3.2.1]OCTANE-2,3,4-TRIOL DERIVATIVES
Compounds of Formula (A) and (B) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in... |
|
|
US20130059851 |
Methods of Diagnosing and Treating Cancer in Patients Having or Developing Resistance to a First Cancer Therapy
A method of identifying a subject having cancer who is likely to benefit from treatment with a combination therapy with a RAF inhibitor and a second inhibitor is provided. A method of treating... |
|
|
US20120277302 |
EQUOL-CONTAINING FERMENTATION PRODUCT OF SOYBEAN EMBRYONIC AXIS, AND METHOD FOR PRODUCTION THEREOF
An object of the invention is to provide an equol-containing fermented soybean hypocotyl material that is useful for foods, pharmaceutical preparations, cosmetic products, etc. The... |
|
|
US20120095090 |
NOVEL COMPOSITION AND METHOD FOR STABILIZING THE SAME
Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved... |
|
|
US20120014883 |
Compositions Comprising Derivatives Of Essential Oil Compounds And Use In Personal Care Products
Compositions containing one or more derivatives of essential oil compounds for use in personal care compositions, such as compositions for oral, throat and skin care are disclosed. These... |
|
|
US20120003337 |
HEALTH SUPPLEMENTS CONTAINING PHYTO-OESTROGENS, ANALOGUES OR METABOLITES THEREOF
Compositions enriched with natural phyto-oestrogens or analogues thereof selected from Genistein, Daidzein, Formononetin and Biochanin A. These may be used as food additives, tablets or capsules... |
|
|
US20110305782 |
METHODS OF CHOLESTEROL REDUCTION USING ISOFLAVONES
This invention relates to natural products containing phyto-oestrogens, or phyto-oestrogen analogues, which have various beneficial physiological effects in man, and which have a variety of uses,... |
|
|
US20110104305 |
COMPOUNDS AND METHODS FOR THIOL-CONTAINING COMPOUND EFFLUX AND CANCER TREATMENT
Methods for therapy of cystic fibrosis and other conditions such as cancer are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a... |
|
|
US20110065783 |
HYDROXYLATED NEBIVOLOL METABOLITES
Hydroxylated nebivolol metabolites increase NO release from human endothelial cell preparations in a concentration dependent fashion following acute administration. In addition, hydroxylated... |
|
|
US20100075926 |
ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL
The invention provides methods and compounds for the treatment of neurological disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, ALS (Amyotrophic Lateral... |
|
|
US20090291998 |
EPONEMYCIN AND EPOXOMICIN ANALOGS AND USES THEREOF
The present invention provides compounds having formula (1): wherein R1-R6, A, J, D, A, G, Q, w, x, y, and z are as described generally and in classes and subclasses herein, and additionally... |
|
|
US20080318866 |
MEDICAMENT FOR TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS, HYPERTENSION AND/OR METABOLIC SYNDROME
A substance including the chemical structures of bicyclo [3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the... |